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Foxp3+ T regulatory (Treg) cells prevent inflamma-
tory disease but the mechanistic basis of suppres-
sion is not understood completely. Gene silencing
by RNA interference can act in a cell-autonomous
and non-cell-autonomousmanner, providingmecha-
nisms of intercellular regulation. Here, we demon-
strate that non-cell-autonomous gene silencing,
mediated by miRNA-containing exosomes, is a
mechanism employed by Treg cells to suppress
T-cell-mediated disease. Treg cells transferred mi-
croRNAs (miRNA) to various immune cells, including
T helper 1 (Th1) cells, suppressing Th1 cell prolifera-
tion and cytokine secretion. Use of Dicer-deficient or
Rab27a and Rab27b double-deficient Treg cells to
disrupt miRNA biogenesis or the exosomal pathway,
respectively, established a requirement for miRNAs
and exosomes for Treg-cell-mediated suppression.
Transcriptional analysis and miRNA inhibitor studies
showed that exosome-mediated transfer of Let-7d
fromTreg cell to Th1 cells contributed to suppression
and prevention of systemic disease. These studies
reveal a mechanism of Treg-cell-mediated suppres-
sion mediated by miRNA-containing exosomes.
INTRODUCTION
Inflammation after infection, autoimmunity, or allergy is
controlled to prevent immune-mediated pathologies (Nathan,
2002). T regulatory (Treg) cells prevent such inflammatory dam-
age (Josefowicz et al., 2012; Sakaguchi, 2000; Shevach, 2000),
but the precise mechanisms of suppression are incompletely
understood. RNA interference (RNAi), pioneered in plants (Voin-
net and Baulcombe, 1997) andworms (Fire et al., 1998), provides
a mechanism of sequence-specific gene silencing, which func-
tions in a cell-autonomous and non-cell-autonomous manner.
Multivesicular bodies (MVBs) release intracellular vesicles
formed from endosomal membrane, including exosomes, that
have encapsulated cystolic contents (The´ry, 2011). This exoso-
mal pathway can sample miRNAs from donor cells and transfer
miRNAs and other bioactive material between cells (Valadi et al.,2007), providing a vehicle for intercellular communication.
Indeed, miRNA-containing exosomes have been isolated from
various bodily fluids (The´ry, 2011) and can regulate gene expres-
sion in various target cells (Kosaka et al., 2010).
Within the immune system, exosomes are released by a vari-
ety of innate (The´ry et al., 2002; Valadi et al., 2007; Zitvogel
et al., 1998) and adaptive (Bryniarski et al., 2013; Mittelbrunn
et al., 2011; Raposo et al., 1996; Smyth et al., 2013) immune cells
with thymus-derived exosomes capable of influencing lympho-
cyte differentiation (Wang et al., 2008). Furthermore, T-lympho-
cyte-derived exosomes can transfer miRNAs to dendritic cells,
modulating gene expression in recipient cells (Mittelbrunn
et al., 2011). In this study, we tested whether Treg cells release
exosomes and whether miRNA-containing exosomes contribute
to Treg-cell-mediated control of immune responses. In sum-
mary, we observed that Treg cells released a significant quantity
of miRNA-containing exosomes and that miRNAs were trans-
ferred to Th1 cells in vitro and in vivo. Coculture and transcrip-
tional analyses identified that Treg cells transferred Let-7d to
Th1 cells, suppressing Th1 cell proliferation and IFN-g secretion.
More importantly, miRNA biogenesis and the ability of Treg cells
to release exosomes were both required for Treg cells to sup-
press Th1 cell proliferation in vivo and prevent systemic disease.
RESULTS
Treg Cells Release Exosomes
Exosome release was quantified from different lymphocytes,
including CD4+ and CD8+ naive T cells, T helper 1 (Th1) and
Th17 cells, Treg cells, and CD19+ B cells, using CD63 as an exo-
somal surface marker, which correlated with other exosome
markers including CD9 and CD81 (Figures S1A–S1C available
online). After activation of various T cells, with anti-CD3 and
anti-CD28, or B cells, with CD40L and LPS, Treg cells released
more CD63+ exosomes per cell than other lymphocytes, despite
only a minor change in cell number (Figures 1A, S1D, and S1E).
Factors that regulate Treg cells, including interleukin 2 (IL-2)
(Boyman et al., 2006; Fontenot et al., 2005), Amphiregulin
(Areg) (Zaiss et al., 2013), or all-trans retinoic acid (AT-RA) (Nolt-
ing et al., 2009), also regulated exosome release (Figures S1F
and S1G) without any appreciable change in Treg cell number
or metabolic activity over the culture period (Figure S1H).
Despite 60% fewer exosomes released from naive T cells
compared to Treg cells, exosome release from naive CD4+
T cells was also regulated by IL-2 (Figure S1G). Exosome releaseImmunity 41, 89–103, July 17, 2014 ª2014 The Authors 89
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Treg-Cell-Derived miRNA-Containing Exosomesis regulated by changes in intracellular calcium (Ca2+) (Savina
et al., 2003), hypoxia (King et al., 2012), and sphingolipid cer-
amide synthesis (Trajkovic et al., 2008). Similarly, exosome
release by Treg cells was regulated by the calcium ionophore,
monensin, hypoxia, and ceramide biosynthesis (Figure S1F).
miRNAs are essential for Treg-cell-autonomous functions (Lis-
ton et al., 2008; Zhou et al., 2008). However, miRNAs have also
been observed in exosomes, released from Jurkat T cell lines
(Mittelbrunn et al., 2011) and other T cell clones (Nolte-’t Hoen
et al., 2012), raising the possibility thatmiRNAsmay also function
in anon-T-cell-autonomousmanner.Usinggenome-widemiRNA
analysis, we found that Treg-cell-derived exosomes contained
both premature and mature miRNAs (Figures 1B–1E, Table S1).
Furthermore, the composition of miRNAs in Treg-cell-derived
exosomes was distinct from that of parental Treg cells. Of note,
the most abundant miRNAs in Treg-cell-derived exosomes
(miR-466 family [Druz et al., 2011], miR-195 [Yang et al., 2012],
andmiR-16 [Cai et al., 2012]) have either proapoptotic or antipro-
liferative properties. Microarray analysis of Th1- and Th2-cell-
derived exosomes revealed a different suite of miRNAs to those
identified in Treg-cell-derived exosomes (Figures S1I–S1K), sug-
gesting that different T cells release different miRNAs. In addition
tomiRNAs, genome-widemRNA analysis identifiedmanymRNA
transcripts enriched in Treg-cell-derived exosomes (Figure S2
and Table S2). Unbiased pathway analysis of mRNA transcripts
in Treg-cell-derived exosomes identified a profile consistent
with the suppression of T cells (Figure S2D), suggesting that
Treg-cell-derived exosomes may be involved in T cell regulation.
miRNAs Are Transferred from Treg Cells to
Conventional T Effector Cells In Vitro and In Vivo
To test whther RNA was transferred between immune cells,
we developed a flow-cytometry-based system using Treg
cells transfected with fluorescent oligonucleotide duplexes (FL-
dsRNA) (Figure 2A), allowing us to track Treg-cell-derived
dsRNA in single cells. When we cocultured Treg cells with other
leukocytes, Treg cells transferred FL-dsRNA to 60% of cocul-
tured naive T cells (CD3+CD4+CD25–) or other Treg cells
(CD3+CD4+Foxp3rfp+CD25+) and to 40% of cocultured DCs
(CD11c+MHCIIhi) or B cells (CD3–CD19+) (Figure 2B). Using an
in vitro suppression assay with a decreasing number of FL-
dsRNA-transfected Treg cells to conventional T effector (Teff)
cells, we observed a dose-dependent transfer of FL-dsRNA to
Teff cells (Figure 2C), with the amount of FL-dsRNA transferred
correlated with the decrease in target cell proliferation. These
data suggest that transfer of RNA from Treg cells to conventional
T cells may be involved in the suppression of conventional
T cells.
RNA can be transferred from T cells to antigen-presenting
cells (APCs) (Mittelbrunn et al., 2011) and between various
APC populations (Montecalvo et al., 2012). However, addition
of APCs to Treg cell and conventional T cell cocultures had noFigure 1. Treg Cells Produce More Exosomes than Other Lymphocyte
(A) Exosomes were purified and quantified by CD63 ELISA from the supernatant
(B) Total RNA was isolated from three biological replicates of Treg cells or purifie
(C–E) Premature (C) and mature upregulated (D) and mature downregulated (E) m
premature and mature miRNAs in parental Treg cells. A representative of two or
Error bars are SD.impact on RNA transfer to conventional T cells (Figure 2D).
HIV-1 virus can be transferred between T cells in nanotubules
(Sowinski et al., 2008) in a cell-contact-dependent manner.
However, when Treg cells and conventional T cells were cultured
in a transwell system, physically separating Treg cell and con-
ventional T cells beyond the reach of nanotubes, RNA transfer
was only slightly reduced (Figure 2E), suggesting transfer of
RNA by an extracellular microvesicle-related mechanism.
To determine whether FL-dsRNA was being transferred into
the cytoplasm of recipient conventional T cells from donor
Treg cells, rather than simply decorating the surface of recipient
cells, we cocultured Treg cells and conventional T cells and then
FACS purified each population after coculture. Using anti-
CD45.1 membrane stain on the recipient cell, we verified that
the FL-dsRNA was indeed delivered inside the recipient cell
(Figure 2F).
Next, we took advantage of the dependency on Dicer for
mature miRNA processing (Hutva´gner et al., 2001) to formally
test whethermiRNAswere transferred from Treg cells to conven-
tional T cells in vitro. Treg cells from miRNA-sufficient CD45.2
WT mice were cocultured with miRNA-deficient conventional
T cells from congenic CD45.1+Cd4CreDicerfl/flR26eyfp (Dicer–/–)
mice, which were labeled with cell trace violet (Figure 3A). This
system allowed us to (1) accurately discriminate and separate
each population, (2) assess proliferation of Dicer–/– conventional
T cells, and (3) repurify Dicer–/– conventional T cells after cocul-
ture to identify the presence of any acquired miRNAs. As ex-
pected, Treg cells suppressed (Figure 3B) and transcriptionally
altered (Figure 3C) Dicer–/– T cells. Several inflammatory cyto-
kines (Il22, Il2, il17a, Ifng) were downregulated in ‘‘suppressed’’
Dicer–/– T cells, with the concomitant increase in several regula-
tory genes (Cd73, Foxp3, Ikzf2 [encoding Helios], and Cd103)
(Figure 3C, Table S3), relative to Dicer–/– T cells cultured alone.
Concurrently,Dicer–/– conventional T cells acquired threemature
(miR-155, Let-7b, and Let-7d) and one pre-miRNA (Hp_miR-
344d-2) from Treg cells (Figures 3D and S2E). Using a Dicer-suf-
ficient (WT) congenic system with CD45.2+ WT Treg cells and
CD45.1+ WT conventional T cells, we also observed an increase
in miR-155, Let-7d, and Let-7b in Dicer-sufficient WT conven-
tional T cells, when cocultured with WT Treg cells (Figure S2F),
further supporting the observation that miRNAs were transferred
between cells. Finally, using CD45.2+ mir155–/– conventional
T cells as recipient cells, cocultured with CD45.1+ mir155+/+
(WT) Treg cells, we confirmed the transfer of miR-155 from
Treg to mir155–/– conventional T cells (Figure S2G). Taken
together these data support the notion that Treg cells transfer
specific miRNAs to conventional T cells, suppressing effector
gene expression and proliferation.
The adoptive transfer of Treg-cell-depleted CD4+CD45RBhi
T cells into T-cell-deficient mice leads to systemic inflammation
(Powrie et al., 1994), which can be prevented by the cotransfer
of Treg cells (Figures S3A–S3E). Despite the loss of miRNAs,s that Carry Distinct miRNAs
of 106 stimulated primary lymphocytes.
d Treg-cell-derived exosomes and used for miRNA microarrays.
iRNAs in Treg-cell-derived exosomes are expressed relative to expression of
three experiments shown.
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Figure 2. Treg Cells Transfer RNA to Various Leukocyte Populations In Vitro
(A) Primary Treg cells (CD4+CD25+Foxp3rfp+) were transfected with fluorescently labeled double stranded RNA (100 nM, FL-dsRNA), rested overnight, washed,
and analyzed for transfection efficiency.
(B) Splenic dendritic cells (CD11c+MHCII+), B cells (CD19+CD4–CD8–CD25–CD44–), Treg cells (CD4+CD25+), and naive T cells (CD4+CD25–CD44–) were cultured
alone (left) or with an equal number of FL-ds RNA-transfected Treg cells (right). The percentage of FL-ds RNA+ nontransfected cocultured cells were quantified
after 48 hr of coculture.
(legend continued on next page)
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Treg-Cell-Derived miRNA-Containing ExosomesDicer–/– CD45RBhi T cells also caused a similar wasting disease
with systemic inflammation (Figures 4A and 4B) and IFN-g pro-
duction (Figures 4C, 4D, and S3F–S3H), which could be pre-
vented by cotransfer of WT, but not Dicer–/–, Treg cells. Because
Dicer–/– CD45RBhi cells retained pathogenicity and sensitivity to
Treg-cell-mediated control, we were able to test whether miR-
NAs were transferred to Dicer–/– CD45RBhi cells in vivo. After
5 weeks, ‘‘pathogenic’’ CD4+Dicer–/– YFP+ (Dicer–/– CD45RBhi
cells transferred alone) or ‘‘regulated’’ CD4+Dicer–/– YFP+
(Dicer–/– CD45RBhi cells cotransferred with WT Treg cells) were
recovered ex vivo to determine whether Dicer–/– cells acquired
miRNAs in vivo (Figure S4A). Consistent with a suppressed state,
regulated CD4+Dicer–/– YFP+ cells had reduced Ifng and Tnf
expression (Figure 4D), compared to pathogenic CD4+Dicer–/–
YFP+ cells. miRNA analysis of CD4+Dicer–/– CD45RBhi cells pre-
transfer and pathogenic and regulated CD4+Dicer–/– YFP+ cells
isolated ex vivo confirmed our in vitro observations (Figure 3)
and identified the presence of miR-155, Let-7b, and Let-7d in
regulated CD4+Dicer–/– YFP+ cells, when WT Treg cells had
been cotransferred (Figure 4E). In contrast, miR-155, Let-7b,
and Let-7d weres not observed in pathogenic CD4+Dicer–/–
YFP+ cells, when no Treg cells were transferred, suggesting
that WT Treg cells either supported or directly transferred miR-
NAs to Dicer–/– cells. Relative to a housekeeping small RNA,
RNU6B, regulated CD4+Dicer–/– YFP+ cells had almost as
much miR-155, Let-7b, and Let-7d as WT Treg cells pretransfer,
suggesting that a large amount of RNA was being transferred.
Of note, WT Treg cells recovered ex vivo had elevated expres-
sion of miR-155, Let-7b, and Let-7d compared to WT Treg cells
pretransfer (Figures 4E and S4B), suggesting that activated Treg
cells also increase transcription of these miRNAs.
Within miRNA-sufficient Rag2–/– hosts, it was conceivable that
the regulated CD4+Dicer–/– YFP+ cells acquired miRNAs from
non-Treg cells. We therefore used an additional control of
Dicer–/– Treg cells, cotransferred with Dicer–/– CD45RBhi cells.
Dicer–/– Treg cells failed to suppress disease. Furthermore,
Dicer–/–CD4+YFP+ cells from mice that were cotransferred with
Dicer–/– Treg cells did not have measurable miR-155, Let-7b,
or Let-7d (Figure 4E). These data demonstrate that Treg-cell-
mediated suppression is accompanied by the transfer of these
three, and possibly other, miRNAs from Treg cells.
Treg-Cell-Mediated Suppression Is Rab27 Dependent
Exosome release requires Rab27a and Rab27b for docking mul-
tivesicular endosomes (MVE) to Rab27 effectors on the plasma
membrane (Fukuda, 2013; Ostrowski et al., 2010; Singh et al.,
2013). To test the role of Rab27 and exosome release, we puri-
fied Treg cells from Rab27ashen/ashenRab27b–/– double knockout(C) FL-dsRNA-transfected Treg cells were cocultured with naive conventional T c
CD28 (5 mg/ml)-coated plates for 3 days. The proliferation of conventional T cells a
were quantified by FACS.
(D) FL-dsRNA-transfected Treg cells were cocultured with naive conventional T c
as indicated, for 24 hr.
(E) FL-dsRNA-transfected Treg cells were cultured with naive conventional T cell
(F) CD4+CD25hiCD45.2+ Treg cells were transfected with FL-dsRNA and cocultur
coculture, FL-dsRNA+ Treg cells or conventional T cells were resorted and analyz
representative of three experiments shown.
Error bars are SD.mice (Rab27-DKO) and stimulated these cells, as above.
Compared to WT and Dicer–/– Treg cells, Rab27-DKO Treg
cells failed to release exosomes with no change in cell viability
(Figures 5A and 5B), confirming the requirement of Rab27 for
exosome release from Treg cells. Under hypoxic conditions,
exosome release was significantly curtailed in WT and Dicer–/–
Treg cells (Figure 5B). Rab27-DKO Treg cells also failed to trans-
fer FL-dsRNA from Treg cells to conventional Teff cells (Fig-
ure 5C), indicating that a Rab27-regulated exosomal pathway
was responsible for transferring RNA between T cells. Further-
more, when cocultured with Th1 cells, Rab27-DKO Treg cells
failed to suppress Th1 cells, similar to Dicer–/– Treg cells (Fig-
ure 5D; Liston et al., 2008; Muljo et al., 2005). These data demon-
strate that Rab27 is essential for (1) exosome release from Treg
cells, (2) RNA transfer from Treg cells to other T cells, and (3)
proficient Treg-cell-mediated suppression in vitro.
Beyond a failure to release exosomes, purified splenic Rab27-
DKO Treg cells were very similar to WT Treg cells, with a compa-
rable frequency (Figure S5A), transcriptional profile (Figures S5B,
qRT-PCR, and S5C, microarray), and intracellular and surface
Treg cell marker and tetraspanin expression profile (Figure S5D),
indicating that Rab27was not required for Treg cell development
or many other features of Treg cells. Furthermore, the deletion of
Rab27 did not impact the ability of Rab27-DKO Th cells to
secrete cytokines (Figure S5E), migrate, and mediate disease
when transferred into Rag2–/– hosts in vivo (Figures S5F–S5H),
indicating that Rab27a and Rab27b, unlike SNAREs and Rho
GTPases (Alonso and Milla´n, 2001), are primarily required for
the exosomal pathway.
To test whether Rab27-dependent exosome release contrib-
uted to Treg cell function in vivo, we transferred WT or Rab27-
DKO Treg cells with WT CD45RBhi T cells into Rag2–/– hosts.
Similar to miRNA-ablated Dicer–/– Treg cells, Rab27-DKO Treg
cells failed to prevent disease with significantly elevated Ifng
expression (Figure 5E), colon shortening (Figure 5F), and weight
loss (Figure 5G) with IFN-g+ T cell recruitment (Figure 5H),
despite a similar frequency of Treg cells observed (Figure S6A).
Failure of Rab27-DKO Treg cells to control effector T cells also
led to significant colonic and systemic inflammation and Ifng
expression (Figures 5I, S6B, and S6C), demonstrating that
Rab27-dependent exosome release was essential for Treg cell
function in vitro and in vivo.
UsingDicer–/–CD4+CD45RBhi effector cells cotransferred with
WT, Dicer–/–, or Rab27-DKO Treg cells, we identified increased
amounts of miR-155, Let-7b, and Let-7d in ex vivo regulated
CD4+Dicer–/– YFP+ cells that were cotransferred with WT, but
not Dicer–/– or Rab27-DKO, Treg cells (Figure 5J). These data
support and extend our in vitro and in vivo observations,ells (CD4+CD25–CD44–) at the indicated ratios on anti-CD3 (1 mg/ml)- and anti-
nd MFI of either transfected Treg cells and nontransfected conventional T cells
ells (CD4+CD25–CD44–) in the presence or absence of APCs (CD11c+MHCII+),
s (CD4+CD25–CD44–) separated by a 0.4 mm filter in a transwell assay system.
ed with CD4+CD25–CD44–CD45.1+ conventional T cells for 24 hr. After 24 hr of
ed by confocal microscopy to identify the cellular location of the FL-dsRNA+. A
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Treg-Cell-Derived miRNA-Containing Exosomesindicating that both Dicer and Rab27 sufficiency in Treg cells is
required for the transfer of miRNAs, suppression of effector
T cells, and prevention of disease. Of note, Rab27-DKO mice
suffered from mild pulmonary inflammation with increased gran-
ulocyte influx and abnormal airway epithelium (Bolasco et al.,
2011). Upon further examination, aged Rab27-DKO mice had
inflammatory foci in the lung, liver, and colon, which may be
due to compromised Treg-cell-mediated immune regulation
(Figure S6D).
Let-7d in Treg-Cell-Derived Exosomes Contributes to
Suppression of Th1 Cells
To determine whether miRNAs in Treg-cell-derived exosomes
were suppressive, we purified exosomes released from WT
and Dicer–/– Treg cells. WT, but not Dicer–/–, Treg cells sup-
pressed Th1 cell proliferation, as previously reported (Liston
et al., 2008; Muljo et al., 2005). Similarly, 107 exosomes from
WT, but not Dicer–/–, Treg cells suppressed Th1 cell proliferation
(Figures 6A, 6B, S6E, and S6F) and IFN-g secretion (Figure 6C),
indicating that exosomes were suppressive in a Dicer-depen-
dent manner. Although Th1 cells could transfer RNA to conven-
tional T cells in vitro (Figure S6G), Th1-cell-derived exosomes
had no impact on Th1 cell differentiation (Figure S6H). Th1 cells
had reduced amounts of Let-7d, compared to naive T cells (Fig-
ure S7A), and Th1-cell-derived exosomes were devoid of Let-7d
(Figure S1I), providing one explanation of why Th1-cell-derived
exosomes could not suppress Th1 cells.
Following the observation that miR-155, Let-7b, and Let-7d
were transferred from Treg cells to conventional T cells, we
tested whether miR-155, Let-7b, or Let-7d, alone or in combina-
tion, were responsible for suppression of Th1 cells. Transfection
of Th1-cell-polarized WT or Dicer–/– T cells with miRNA mimics
of miR-155, Let-7b, Let-7d, or all three miRNAs increased the
expression of each respective miRNA (Figure 6D). Consistent
with previous reports, miR-155 enhanced IFN-g (Banerjee
et al., 2010) and TNF-a secretion, without any appreciable
change in proliferation (Figures 6E and 6F), indicating that
miR-155 promoted, rather than inhibited, Th1 cell responses.
Transfection of Th1 cells with Let-7b had little impact on IFN-g
production or proliferation (Figures 6E and 6F). In contrast, trans-
fection with Let-7d, alone or in combination with either Let-7b or
miR-155, significantly reduced Tnf and Ifng mRNA (Figure 6E),
Th1 cell proliferation, and IFN-g secretion (Figure 6F), suggesting
that the transfer of Let-7d from Treg cells to Th1 cells may be an
important intermediary of Treg-cell-mediated suppression of
Th1 cells.
Target prediction analyses (Miranda et al., 2006) identified
many putative Let-7d targets involved in Th1 cells (Il12r,
Tbx21, Stat1 and Stat4, and Ifng). We therefore analyzed the
miRNA and mRNA profile of FACS-purified IFN-gyfp+ Th1 cells,Figure 3. Treg Cells Transfer miR-155, Let-7b, and Let-7d to T Cells In
(A) FACS-purified Dicer–/– cell-trace violet (CTV)-labeled conventional T cells (CD
Treg cells (CD45.2+CD4+CD25+Foxp3rfp) for 3 days on anti-CD3 (1 mg/ml)- and a
(B) Proliferation of Dicer–/– conventional Teff cells was assessed and FACS sorte
(C and D) RNA was extracted from three biological replicates of CD45.1+Cd4Cre D
cells. Heatmaps of differentially expressed genes used for mRNA (C) or miRNA (D
genes in CD45.1+Dicer–/– conventional T cells cocultured with WT Treg cells,
representative of three experiments shown, with three biological replicates usedcompared to naive T cells, and identified reduced premature
and mature Let-7d with an increase in many Let-7d target genes
(Figure S7A). Specifically, Let-7d was predicted to target Ptgs2
(Cox-2), which was elevated in Th1 cells (Figures S6 and S7).
Testing the requirement of Cox-2 using a selective Cox-2 inhib-
itor (celecoxib), we noted that Cox-2 inhibition ablated IFN-g
secretion (Figure S6J), indicating that Cox-2 is required for Th1
cell responses. Thus, Let-7d may target Cox-2 in Th1 cells to
regulate IFN-g secretion.
To test whether Let-7d from Treg-cell-derived exosomes
contributed to the suppression of Th1 cell responses in vitro,
we transfected Th1 cells with Let-7d hairpin inhibitors, to inhibit
endogenous or exogenous Let-7d, and cocultured these cells
with Treg cells or exosomes purified from Treg cells. Let-7d in-
hibitor treatment alone did not impact Th1 cell proliferation or
IFN-g secretion in the absence of Treg cells (Figures 7A, 7B,
and S7E). The addition of Treg cells or Treg-cell-derived exo-
somes suppressed Th1 cell proliferation (Figures 7A and 7B)
and IFN-g secretion (Figure 7C). However, Treg cells and Treg-
cell-derived exosomes failed to suppress Let-7d inhibitor-
treated Th1 cells, indicating that sequestering endogenous or
exogenous Let-7d in Th1 cells prevented Treg cell and Treg
cell exosome-mediated suppression (Figures 7A–7C). To further
test whether Let-7d from Treg cells contributed to Treg cell- and
Treg-cell-derived exosome-mediated suppression, we trans-
fected Treg cells with Let-7d hairpin inhibitors or control inhibi-
tors (Figures 7D and S7). Let-7d inhibitor treatment reduced
Let-7d by 50% in Treg cells and by 75% in Treg-cell-derived
exosomes without any appreciable impact on cell viability (Fig-
ure 7D). Let-7d inhibitor-treated Treg cells, but not control inhib-
itor-treated Treg cells (Figure S7), were compromised in their
ability to suppress Th1 cells, and Let-7d-depleted exosomes
had completely lost their ability to suppress Th1 cells (Figures
7D and 7E). Although it remains possible that Let-7d inhibitors
were transferred with Let-7d to Th1 cells in this experimental
setup, taken together with the reduced Let-7d in Th1 cells (Fig-
ure S7) and the fact that Let-7d inhibitor-treated Th1 cells
when cultured alone proliferated and secreted IFN-g similar to
control Th1 cells (Figures 7A and 7B, black bars), these data
indicate that Let-7d contributes to Treg-cell-mediated suppres-
sion and more specifically, that Let-7d was responsible for Treg-
cell-derived exosome-mediated suppression.
Finally, we tested whether Let-7d was required for Treg-cell-
mediated suppression in vivo by transferring mock or Let-7d in-
hibitor-treated WT Treg cells into Rag2–/– hosts with WT
CD45RBhi cells. Transfected Treg cells survive only 7–10 days
in vivo (Kelada et al., 2013), so we transferred Treg cells weekly
for 3 weeks (weeks 2, 3, and 4) before analysis at week 5. Mock-
transfected Treg cells prevented weight loss, Ifng responses,
and intestinal inflammation (Figures 7F–7H). In contrast, Let-7dVitro
45.1+Cd4CreDicerfl/flR26eyfp+CD4+CD25–) were cultured alone or with primary
nti-CD28 (5 mg/ml)-coated plates.
d.
icerfl/fl R26eyfpCD4+CD25 Teff cells after being cultured alone or with WT Treg
) analysis. Graph on right highlights expression of inflammatory and regulatory
expressed relative to CD45.1+Dicer–/– conventional T cells cultured alone. A
in the microarray analysis.
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Figure 4. Dicer–/– Treg Cells Fail to Suppress Systemic Inflammation and TransfermiR-155, Let7-b, and Let-7d to Conventional T Cells In Vivo
Analysis of disease in mice after transfer of Dicer–/– CD4+CD45RBhi T cells with or without cotransfer of WT and Dicer–/– Treg (CD4+CD25hi) cells.
(A) Histopathology of colon sections stained with AB-PAS 5 weeks after cell transfer.
(B) Weight loss after Dicer–/– CD45RBhi cell transfer alone or with WT or Dicer–/– Treg cells.
(C) Expression of Ifng in the colon of mice 5 weeks after cell transfer.
(D) Expression of Ifng and Tnf in ex vivo recovered Dicer–/– conventional T cells (CD4+CD25– eYFP+ Dicer–/–) 5 weeks after cell transfer, as shown in Figure S4,
frommice that received either WT (Dicer–/– +WT Treg cells) or Dicer–/– (Dicer–/– + Dicer–/– Treg cells) CD4+CD25hi Treg cells, mRNA expressed relative to Dicer–/–
CD45RBhi cell transfer alone. A representative of three experiments shown.
(E) Expression of miR-155, Let-7b, Let-7d in eYFP+Dicer–/–CD45Rbhi cells, WT Treg cells, and Dicer–/– Treg cells before transfer (left three bars) or in ex vivo
recovered, FACS-purified Dicer–/– effector T cell (CD4+CD25– eYFP+ Dicer–/–) 5 weeks after cell transfer, from mice that received either Dicer–/– effector T cells
alone,Dicer–/– effector T cells withWT Treg cells, orDicer–/– conventional T cells withDicer–/– Treg cells.Dicer–/– cells (black bars) or Treg cells (white bars). miRNA
expression relative to Rnu6b. A representative of three experiments shown. *p < 0.05.
Error bars are SD.
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Treg-Cell-Derived miRNA-Containing Exosomesinhibitor-treated Treg cells, which released Let-7d-depleted
exosomes (Figure 7C), failed to prevent disease with significant
weight loss, Ifng expression, and colonic inflammation (Figures
7F–7H). Collectively, these data support a mechanism of Treg-96 Immunity 41, 89–103, July 17, 2014 ª2014 The Authorscell-mediated suppression through the release of miRNA-con-
taining exosomes. Furthermore, we identified an important
contribution of Let-7d in mediating this suppression in vitro
and in vivo.
(legend on next page)
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The control of immune responses is critical for survival, with
compromised Treg-cell-mediated control resulting in multior-
gan lymphocytic infiltration, organ failure, and death (Clark
et al., 1999). In this study, we identified a mechanism of Treg-
cell-mediated suppression via non-cell-autonomous gene regu-
lation, mediated by miRNA-containing exosomes. Exosome-
deficient, miRNA-deficient, or Let-7d-ablated Treg cells all
failed to transfer miRNAs and failed to prevent lethal systemic
inflammation. These data support a growing paradigm of non-
cell-autonomous gene regulation previously reported in plants
(Dunoyer et al., 2010) and animals (Sarkies and Miska, 2013;
Valadi et al., 2007) and now demonstrated here, functioning
as an important feature of immune regulation.
The mechanism of exosome release from Treg cells appears
similar to other cells, with the exception of monensin treatment
(Savina et al., 2003), which reduced exosome release from
Treg cells, in contrast to exosome release from the K562 cell
line. This might be due to the particularly sensitive nature of
T cells to calcium changes (Wei et al., 1999) or might indicate
that Golgi-mediated protein secretions support exosome
release. Several overlapping pathways appear to regulate
Foxp3 stability and exosome release, including inactivation of
HIF-1a (Dang et al., 2011), ceramide biosynthesis (Kue et al.,
2013), IL-2 signaling (Fontenot et al., 2005), and Amphiregulin
signaling (Zaiss et al., 2013), suggesting that Foxp3 might
regulate exosome release or that exosome-associated path-
ways might support Foxp3+ cells. In support of the latter, we
identified that miR-155, which is involved in Treg cell develop-
ment (Kohlhaas et al., 2009), was transferred from Treg cell to
conventional T cell with the concomitant upregulation of several
Treg-cell-associated genes in recipient cells (Figure 3).
Whether exosome contents are preferentially packaged
within the parent cell or whether they are randomly assorted
is not well understood. We previously identified significantFigure 5. The GTPase Rab27 Is Needed for Treg Cell Exosome Secreti
Analysis of Treg cell function in vitro and in vivo after transfer of CD4+CD45RBhi T
cells.
(A) WT,Dicer–/–, or Rab27-DKO Treg cells were stimulated on anti-CD3 (1 mg/ml)- a
determined by Alamar blue fluorescence intensity in culture supernatants.
(B) Exosomes were purified from the supernatant of stimulated WT, Dicer–/–, or R
(C) CD45.2+ WT Treg and CD45.2+ Rab27-DKO Treg cells were transfected
(CD4+CD25–CD44–) on anti-CD3 (1 mg/ml)- and anti-CD28 (5 mg/ml)-coated plat
FACS.
(D) Proliferation of violet-labeled in vitro generated Th1 cells cultured alone (red tra
trace) for 3 days. Summarized in bar chart showing the percentage of divided cel
supernatant of cocultured cells.
(E) Rag2–/– mice were given CD4+CD45RBhi T cells with or without transfer of CD4
of mice 5 weeks after cell transfer.
(F) Colon length was measured 5 weeks after cell transfer.
(G) Weekly weight measurements after cell transfer, as in (E).
(H) Percentage of IFN-g+ cells in the mesenteric lymph nodes 5 weeks after cell
(I) Histopathology of large intestine 5 weeks after cell transfer.
(J)Rag2–/– mice were givenDicer–/–CD4+CD45RBhi T cells with or without transfer
Let-7b, Let-7d in eYFP+Dicer–/–CD45Rbhi cells, WT Treg cells,Dicer–/– Treg cells, a
FACS-purified Dicer–/– conventional T cells (CD4+CD25– eYFP+ Dicer–/–) 5 weeks
Dicer–/– conventional T cells withWT Treg,Dicer–/– effector T cells withDicer–/– Tre
(black bars) or Treg cells (white bars). miRNA expression relative to Rnu6b. A rep
Error bars are SD.
98 Immunity 41, 89–103, July 17, 2014 ª2014 The AuthorsmiRNA heterogeneity between distinct Treg cell populations
(Kelada et al., 2013) and found that such heterogeneity was
influenced by the cytokine microenvironment. We report here
that the miRNA content of Treg-cell-derived exosomes is
distinct from the miRNA content of Th1- or Th2-cell-derived
exosomes, indicating that cell/context-specific miRNAs may
be packaged into exosomes. It is tempting to speculate that
the local cytokine environment that shapes the miRNA profile
of Treg cells (Kelada et al., 2013) also influences the exosome
content of divergent T cells and that specific miRNA-containing
exosomes are targeted to different effector cells. Here, we iden-
tified that Let-7d was preferentially packaged and transferred to
Th1 cells, suppressing Th1 cell proliferation and IFN-g secre-
tion; whether different miRNAs are delivered to different Th cells
is unclear.
Similarly, the rate of packaging and transfer of miRNAs be-
tween cells has not been elucidated. Recent reports indicate
that at the immunological synapse between T cells and APCs,
a microvesicle-rich pocket is formed (Choudhuri et al., 2014),
providing a focused and protected region between cells, poten-
tially allowing mass and rapid transfer of material. Whether miR-
NAs are transferred in these regions between T cell and APCwas
unclear from this study. However, for T cell-to-T cell transfer, the
precise mechanism of exosome delivery is yet to be clarified.
Furthermore, the precise mechanism of exosome uptake by
recipient cell remains largely unknown.
Regulatory T cells have a growing repertoire of means to
inhibit and prevent immune cell activation (Shevach, 2009).
With respect to suppression of conventional T cells, current
mechanisms include short-range, cell-contact-dependent
(cytolysis and inhibitory receptor engagement) and potentially
longer-range, cell-contact-independent (IL-2 consumption
and suppressive cytokine secretions, such as IL-10, TGF-b,
and IL-35) mechanisms. However, a combination of cell
contact and secreted mechanisms is most likely optimal for
Treg-cell-mediated suppression. From this study we can addon and Is Essential for Treg Cell Function In Vitro and In Vivo
cells with or without transfer of CD4+CD25hi WT, Dicer–/–, or Rab27-DKO Treg
nd anti-CD28 (5 mg/ml)-coated plates for 3 days. Cell viability/proliferation was
ab27-DKO Treg cells, as in Figure 1.
with FL-dsRNA and cocultured naive WT CD45.1+ conventional Teff cells
es. After 24 hr, cells were stained for CD45.1 and analyzed for FL-dsRNA by
ce in all four plots) or in presence ofWT,Dicer–/–, orRab27-DKO Treg cells (blue
ls in the presence of the indicated Treg cell population. IFN-gmeasured in the
+CD25hi WT, Dicer–/–, or Rab27-DKO Treg cells. Expression of Ifng in the colon
transfer.
of CD4+CD25hi WT,Dicer–/–, orRab27-DKO Treg cells. Expression ofmiR-155,
ndRab27-DKO Treg cells before transfer (left four bars) or in ex vivo recovered,
after cell transfer, from mice that received either Dicer–/– effector T cells alone,
g cells, orDicer–/– conventional T cells withRab27-DKOTreg cells.Dicer–/– cells
resentative of at least three experiments shown. *p < 0.05.
A B C
D E F
Figure 6. Treg-Cell-Derived Exosomes and Exogenous Let-7d Suppress Th1 Cell Proliferation and IFN-g Secretion
(A–C) Cell trace violet-labeled Th1 cells were cultured with WT or Dicer–/– Treg cells, as in Figure 5D, or with exosomes recovered from WT or Dicer–/– Treg cells.
(A) Cell proliferation was determined by cell trace violet dilution.
(B) Alamar blue fluorescence intensity was determined in culture supernatants.
(C) IFN-g secretion determined was determined in culture supernatants by ELISA.
Th1 cells were transfected with miR-155, Let-7b, Let-7d miRNA mimics (100 nM), as indicated.
(D) miR-155, Let-7b, and Let-7d were measured in Th1 cells, 24 hr after transfection with miR-155, Let-7b, Let-7d miRNAmimics. miRNAs are expressed relative
to mock-transfected cells.
(E) Tnf and Ifng expression was measured in Th1 cells, 24 hr after transfection with miR-155, Let-7b, Let-7d miRNA mimics. mRNAs are expressed relative to
mock-transfected cells.
(F) Proliferation (top) of transfected cells was determined by Alamar blue fluorescence tin culture supernatants. IFN-g secretion (bottom) was determined by
ELISA. A representative of three experiments shown.
*p < 0.05. Error bars are SD.
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Figure 7. Let-7d from Treg Cells or Treg-Cell-Derived Exosomes Is Required to Suppress Th1 Cell Responses
(A–C) Th1 cells were transfectedwith Let-7dmiRNA short hairpin inhibitors (100 nM), or mock transfected as indicated and coculturedwith Treg cells or Treg-cell-
derived exosomes.
(A) Proliferation of violet cell trace-labeled Th1 cells cultured alone or in presence of Treg cells or Treg-cell-derived exosomes for 3 days.
(B) IFN-g measured in the supernatant of cocultured cells.
(C) Freshly isolated WT Treg cells were transfected with Let-7d miRNA short hairpin inhibitors (100 nM), or mock transfected as indicated, with cell proliferation
determined by Alamar blue (left) and Let-7d expression analyzed in Treg cells (middle) or in Treg-cell-derived exosomes (right).
(D) Violet cell trace-labeled Th1 cells were cocultured with mock (M)- or Let-7d inhibitor-transfected Treg cells (Inh) or with exosomes isolated from Mock (M)- or
Let-7d inhibitor-transfected Treg cells (Inh), as indicated. Proliferation of violet cell trace-labeled Th1 cells was determined after 3 days. Summarized in bar chart
showing the percentage of divided cells in each condition.
(E) IFN-g measured in the supernatant of cocultured cells, as in (D).
(F–H) Analysis of disease in mice at week 5 after transfer of WT CD4+CD45RBhi T cells with or without mock-transfected or Let-7d inhibitor-transfected Treg cells.
105 Treg cells were adoptively transferred on week 2, 3, and 4.
(legend continued on next page)
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Treg-Cell-Derived miRNA-Containing Exosomesnon-cell-autonomous gene silencing as a mode of cell-contact-
independent Treg-cell-mediated suppression, via transfer of
miRNAs. We observed that isolated Treg-cell-derived exosomes
can suppress conventional T cells; however, this was not as effi-
cient as Treg cells, indicating that exosome-mediated transfer
and additional mechanisms are indeed required for optimal sup-
pression. Although cell contact was not required for the transfer
of RNA between cells, whether cell contact allows more rapid
and focused transfer, as mentioned above, is currently under
investigation. Together these observations suggest that exo-
some-mediated transfer of miRNAs may collaborate with other
Treg cell mechanisms for optimal suppression. For example,
Treg cells anchored to other T cells via galectins (Garı´n et al.,
2007) or to APCs via CTLA-4 might be required for most efficient
delivery of miRNA-containing exosomes to target cells. From
data presented here, the ability of Treg cells to release microve-
sicles in a Rab27-dependent manner, and specifically transfer
Let-7d to target cells, was required for optimal Treg-cell-medi-
ated suppression in vitro and in vivo. Whether this mechanism
works in concert with other previously described Treg-cell-asso-
ciated mechanisms or not is currently unclear.
Of the many potential Let-7d targets in recipient Th1 cells, we
identified Ptgs2 (Cox-2) as a credible candidate (Figures S6 and
S7). Cox-2 is involved in Th1-cell-mediated responses and is
responsible for lethal T-cell-mediated inflammation (Brewer
et al., 2003; In˜iguez et al., 1999). Whether Treg-cell-derived
Let-7d-containing exosomes directly target Cox-2 in Th cells,
analogous to a ‘‘Cox-2 inhibitor,’’ is currently unclear. Support-
ing this pathway we observed reduced expression of Cox-2
and other Th1-cell-associated genes in suppressed T cells
in vitro, concomitant with the acquisition of Let-7d from WT
Treg cells. Furthermore, treatment of T cells with a COX-2 in-
hibitor reduced IFN-g production by Th1 cells (Figure S6J).
Given that Cox-2 inhibitors can prevent Th1-cell-mediated
experimental autoimmunity (Muthian et al., 2006; Ni et al.,
2007) and colitis (Paiotti et al., 2012; Zrieki et al., 2010), target-
ing of Cox-2 by Treg-cell-derived Let-7d may be a specific
Treg-cell-mediated function to prevent lethal Th1-cell-mediated
inflammation. In summary, this mechanism of Treg-cell-medi-
ated suppression opens up the possibility that Treg cells pack-
age and deliver different proteins and RNA species, including
miRNAs as we report here, to different cells at different times
in a context-dependent manner.
EXPERIMENTAL PROCEDURES
Animals
Female C57BL/6, Rag2–/–, CD45.1 Cd4CreDicerfl/fl R26eyfp (Dicer–/–),
Rab27aashen/ashenb–/– (Rab27-DKO), miR155–/–, Il4gfpIfngyfpIl17aCre (Hirota
et al., 2013), R26eFP635, Foxp3rfp, and Foxp3gfp 6- to 8-week-old (or as indi-
cated) animals were bred and kept in the specific-pathogen-free facility at
the Medical Research Council, NIMR. All animal experiments were performed
according to institutional guidelines and the UK Home Office regulations. A
minimum of five mice per group was used in each experiment, unless
indicated.(F) Weight loss measured weekly.
(G) Ifng expression measured in the colon at week 5 after cell transfer.
(H) Histopathology of large intestine 5 weeks after cell transfer. A representative
*p < 0.05. Error bars are SD.Induction of Colitis and Systemic Inflammation
Rag2/ mice were injected i.v. with 5 3 105 FACS-purified CD4+CD45RBhi
T cells with or without 105 CD4+CD25+ Treg cells 2 weeks later, as previously
described (Powrie et al., 1994).
In Vitro Cell Culture, Reagents, and Stimulation Assays
Primary cells were isolated from naive or diseased spleen, lymph nodes, or
tissue, as indicated, by mechanical disruption. Full details of antibodies
used can be found in Supplemental Experimental Procedures. For suppres-
sion assays, 104 Teff cells were labeled with cell trace violet (Invitrogen) as
per manufacturer’s guidelines and stimulated with plate-bound anti-CD3
(1 mg/ml) and soluble CD28 (5 mg/ml) for 3 days in the presence or absence
of Treg cells, at the indicated ratios.
RNA Extraction, RT-PCR, and Microarray
FACS-purified cells or isolated exosomes were stored in RLT lysis buffer at
–80C until RNA was extracted using RNeasy mini spin columns (QIAGEN).
For RT-PCR, miScript RT or Quantitect RT was performed, according to
manufacturer’s recommendations (QIAGEN). Real-time RT-PCR was per-
formed on an ABI Prism 7900HT Sequence Detection System (Applied Bio-
systems) with relative quantities of mRNA and miRNA determined using
SYBR Green PCR Master Mix (Applied Biosystems) and by the comparative
threshold cycle method as described by Applied Biosystems for the ABI Prism
7700/7900HT Sequence Detection Systems. mRNA levels were normalized to
HPRT and miRNA levels were normalized to RNU6B and then expressed as a
relative increase or decrease compared with levels in controls, or as indicated.
ELISA
IFN-g was measured by ELISA using cytokine capture and biotinylated detec-
tion antibodies (R&D Systems). The concentration of IFN-g was determined
from a serial-fold diluted standard curve with OD read at 450 nm in an ELISA
reader.
miRNA Mimic and Hairpin Inhibitor Transfection
Cells were transfected with 100 nM of FL-dsRNA (SiGlo, Thermo Scientific
Dharmacon) or BloCKiT (Invitrogen), miR-155mimics, Let-7dmimics or hairpin
inhibitors, Let-7b mimics, Cel-miR-67 hairpin inhibitors, or Cel-miR-239b
hairpin inhibitors (Thermo Scientific Dharmacon) or MOCK transfected using
Nucelofection reagents according to manufacturer’s recommendations
(Amaxa).
Exosome Isolation and Analysis
Throughout these studies, complete media with exosome-depleted FCS
(following 100,0003 g centrifugation) was used (Thery et al., 2006). Exosomes
were purified by a combination of ultracentrifugation and using Exoquick solu-
tion (SBI System Bioscience) (Taylor et al., 2011), as previously reported and
tested (King et al., 2012).
Full details of exosome isolation and other methods can be found in the
Supplemental Experimental Procedures.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSEXXXX.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2014.05.019.of three experiments shown.
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